Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
06/2003
06/04/2003CN1422250A Alpha-sulfin-and alpha-sulfonamino acid amide derivatives
06/03/2003USRE38133 Kappa agonist compounds and pharmaceutical formulations thereof
06/03/2003US6573379 Method for preparing halomethyl heterocyclic compounds
06/03/2003US6573268 Administering novel azolidinedione derivatives, tautomers, stereoisomers, polymorphs, pharmaceutically acceptable salts and solvates to treat diabetes
06/03/2003US6573266 Piperazine derivatives and their use as anti-inflammatory agents
06/03/2003US6573264 Heteroaryl alkyl piperazine derivatives
05/2003
05/30/2003WO2003043988A1 Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient
05/30/2003WO2003043735A2 Aromatic compounds containing nitrogen and p-functionalized amines, the production thereof and their use in catalytic reactions
05/30/2003WO2002070509A3 Antagonists of mcp-1 function and methods of use thereof
05/30/2003CA2467752A1 Piperidin-2-one derivative compounds and pharmaceutical composition comprising the same as active ingredient
05/29/2003US20030100755 For example (2S, 3S, 5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(2S-(1-tetrahydro-pyrimid-2-onyl)-3-methyl butanoyl)amino-1,6-diphenylhexane; HIV therapy
05/29/2003US20030100569 Anti-mycobacterial compounds
05/28/2003EP1314721A1 Novel propenohydroxamic acid derivatives
05/28/2003EP1313696A2 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors
05/28/2003EP1313477A1 Compounds and methods
05/28/2003EP1097145B1 Polyhydroalkylpyrazine derivatives and their preparation and medicines containing them
05/28/2003EP0912528B1 Processes for producing phenoxy propionic acid derivatives
05/28/2003EP0788360B1 Boronic ester and acid compounds, synthesis and uses
05/28/2003CN1420882A Substd. oxoazaheterocyclyl compounds
05/28/2003CN1420870A Modulators of dopamine neurotransmission
05/28/2003CN1109544C Beta-alkoxyacrylates against malaria
05/27/2003US6570027 Method of preparing intermediates useful in synthesis of retroviral protease inhibitors
05/27/2003US6569361 Polycondensation or polyaddition of electrochromic monomers are used in devices for variable transparency
05/22/2003WO2003042191A1 Benzamide and heteroarylamide as p2x7 receptor antagonists
05/22/2003WO2003042187A1 Serin protease inhibitors
05/22/2003WO2003042168A1 NOVEL α-OXYGENATED OR α-THIOLATED CARBOXYLIC ACID PHENETHYLAMIDE DERIVATIVES
05/22/2003WO2003042167A1 NOVEL α-OXYGENATED OR α-THIOLATED CARBOXYLIC ACID PENETHYLAMIDE DERIVATIVES
05/22/2003WO2003041728A1 Novel phenyl-propargylether derivatives
05/22/2003US20030095958 Inhibiting beta amyloid converting enzyme responsible for A beta peptide cleavage to treat Alzheimer's Disease, Down's Syndrome, etc.
05/22/2003CA2464775A1 Novel alpha-oxygenated or alpha-thiolated carboxylic acid phenethylamide derivatives
05/21/2003EP1312609A1 Boronic ester and acid compounds, synthesis and uses
05/21/2003EP1311478A1 Novel thiourea compounds and the pharmaceutical compositions containing the same
05/21/2003EP1311473A2 Novel compounds inhibiting factor xa activity
05/21/2003EP1311192A1 $g(in vivo) imaging
05/21/2003CN1419450A Nitrite salts of antimicrobial agents
05/20/2003US6566566 Dimerization of a C6-12 olefin mixture in which the hexene isomer fraction has less than 30% by weight of linear isomers in the presence of a nickel catalyst; derivatization to give primary alcohols, and optional subsequent alkoxylation
05/20/2003US6566380 For therapy of cardiac arrhythmias
05/20/2003US6566292 Process for the enhancement of the cycle life of a zinc-chromium based catalyst in the synthesis of 2-methylpyrazine
05/20/2003US6565614 Cationic oxidation bases, their use for oxidation dyeing of keratin fibres, dyeing compositions and dyeing methods
05/20/2003CA2223016C Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of her-2 autophosphorylation properties
05/20/2003CA2110693C Amino acid derivative anticonvulsant
05/15/2003WO2003040402A2 Alpha-helix mimicry by a class of organic molecules
05/15/2003WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003WO2003039457A2 Anti-mycobacterial compounds
05/15/2003WO2002102983A3 Oligomers and polymers of di-substituted cyclic imino carboxylic acids
05/15/2003US20030092910 Piperazine derivatives and process for the preparation thereof
05/15/2003US20030092704 Novel arylglycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
05/15/2003US20030092702 Antiinflammatory agents; autoimmune disease; autoimmune diseases
05/15/2003US20030092694 Central nervous system disorders; side effect reduction
05/15/2003US20030092679 Novel non-convalent thrombin inhibitors
05/15/2003US20030092678 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases
05/15/2003CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/14/2003EP1310495A2 Glycidyl amines and their use in the preparation of HIV protease inhibitors
05/14/2003EP1309565A1 Heterocyclic mutilin esters and their use as antibacterials
05/14/2003CN1418197A Piperidine and piperazine substituted N-hydroxyformamides as inhibitors of metalloproteinases
05/14/2003CN1418191A Novel thiourea derivatives and the pharmaceutical compositions containing thd same
05/14/2003CN1108301C Inhibitors of microsomal triglyceride transfer protein and mothed
05/14/2003CN1108294C Piperazine-2,5-dione derivatives as modulators of multidrug resistance
05/14/2003CN1108290C Urea derivatives
05/13/2003US6562972 Method for preparing quinoxaline-5- and 6-carboxylic acids (I) which comprises contacting an aqueous alkaline suspension of a 5- or 6-halomethyl quinoxaline (II) with oxygen in the presence of a transition metal catalyst, to form the
05/13/2003US6562873 Containing oxy-chloro components including chlorine dioxide, hypochlorite, perchlorate or chlorite components
05/13/2003US6562842 Osteoporosis, oral diseases
05/13/2003US6562825 For treating inflammatory disease including asthma and allergic diseases, as well as autoimmune pathologies
05/13/2003US6562817 Suppressants of the IgE production
05/13/2003US6562813 Aralkyl and aralkylidene heterocyclic lactams and imides
05/08/2003WO2003037879A1 Substituted (1h)-quinoxalin-2-one compounds and substituted 4-aryl- and 4-heteroarylcyclohexane compounds
05/08/2003WO2003037872A1 Therapeutic quinoline compounds with 5-ht-antagonistic properties
05/08/2003WO2003037871A1 Therapeutic quinolone compounds with 5-ht-antagonistic properties
05/08/2003US20030088122 Method of preparing amino carboxylic acids
05/08/2003US20030087914 Citric acid salt of 4-(3,4-dichlorophenyl)-2-(2-(4-methylpiperazin-1-yl)-benzylidene) -thiomorpholin-3-one; serotonin receptor antagonists
05/08/2003US20030087306 Methods for identifying novel multimeric agents that modulate receptors
05/08/2003US20030087151 Low melting point
05/08/2003CA2465350A1 Therapeutic quinoline compounds with 5-ht-antagonistic properties
05/08/2003CA2465344A1 Therapeutic quinolone compounds with 5-ht-antagonistic properties
05/08/2003CA2465061A1 Substituted (1h)-quinoxalin-2-one compounds and substituted 4-aryl- and 4-heteroarylcyclohexane compounds
05/07/2003EP0966454B1 Disubstituted bicyclic heterocycles, their production and use as medicaments
05/07/2003EP0889863B1 Surface modified carbonate materials
05/07/2003EP0749433B1 (4,4-difluorobut-3-enylthio)-substituted heterocyclic or carbocyclic ring compounds having pesticidal activity
05/07/2003CN1415606A Method of preparing compound of 0-substituted sulphonyl propylhomoserin class
05/06/2003US6559308 The present invention relates to a method for preparing quinoxaline-5- and 6-carboxylic acids. The method comprises contacting an aqueous suspension of a 5- or 6-hydroxymethyl quinoxaline with oxygen in the presence of a transition metal
05/02/2003EP1305445A1 Dark quenchers for donor-acceptor energy transfer
05/02/2003EP1305304A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor
05/02/2003EP1305288A1 Potassium channel inhibitors
05/02/2003EP1305278A1 Ruthenium complexes and their use in asymmetric hydrogenation
05/02/2003EP1305047A2 Non-peptide ccr1 receptor antagonists in combination with cyclosporin a for the treatment of heart transplant rejection
05/02/2003EP1305028A2 Antimicrobial biaryl compounds
05/02/2003EP1086103B1 Pyrido 2,3-b]indolizine derivatives and aza analogues thereof; crf 1 specific ligands
05/02/2003EP0999840B1 Use of a draflazine analogue for treating pain
05/01/2003WO2003035627A1 Piperazine derivatives with ccr1 receptor antagonist activity
05/01/2003WO2003035609A1 Zwitterionic imides
05/01/2003WO2003035602A1 Lipid modulators
05/01/2003WO2002067866A3 Piperazine derivatives as metalloprotease inhibitors
05/01/2003US20030083357 Oxime derivatives for the treatment of dyslipidemia and hypercholesteremia
05/01/2003US20030083335 CCR1 receptor antagonists; inhibitors of MIP-1 alpha (CCL3) binding to its receptor CCR1 found on inflammatory and immunomodulatory cells; macrophage inflammatory protein (MIP)
05/01/2003US20030083332 N-heterocyclic derivatives as NOS inhibitors
05/01/2003US20030082631 Detecting modulator of peroxisome proliferator-activated receptor; obtain sample contain proxisome receptor, incubate with test agent, monitor sample for adjustment in receptor activity
05/01/2003US20030082547 Non-fluorescent quencher compounds and biomolecular assays
05/01/2003CA2463290A1 Zwitterionic imides
04/2003
04/30/2003CN1414956A Substituted piperazine derivatives as MIP inhibitors
04/30/2003CN1413991A Method of fixed bed continuous synthetising piperazine series compound
1 ... 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 ... 187